查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球乳房植入物市场：按性别、最终用户、分销管道、关键地区、产业趋势和预测（2023-2035）
市场调查报告书
商品编码
1411405

全球乳房植入物市场：按性别、最终用户、分销管道、关键地区、产业趋势和预测（2023-2035）

Breast Implants Market, 2023-2035 - Distribution by Gender, End User, Distribution Channel and Key Geographical Regions : Industry Trends and Global Forecasts
出版日期: | 出版商: Roots Analysis | 英文 233 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

2023 年，全球乳房植入物市场规模达 192 亿美元，在预测期内（2023-2035 年）复合年增长率为 9.6%。

乳房植入物是塑身和美容手术中最有前途的治疗选择之一。 事实上，到 2022 年，乳房植入手术将成为世界上最受欢迎的整容手术之一，全球将进行超过 217 万例手术。 乳房植入手术中最常用的材料是盐水植入物和硅胶植入物。 然而，整形外科医师使用硅胶植入物的比例较大，占所有整形手术的17.6%。 这主要是由于硅胶植入物的交联率高。 此外，如果植入物破裂或洩漏，凝胶也不会进入体内。 乳癌也呈现上升趋势，占全球每年新发癌症病例的12.5%。

隆乳手术的目的是为了改善乳房美观。 患者可以根据自己的喜好选择最佳的选择。 这种治疗的效果可以持续20多年。 然而，植体破裂的几率每年增加 1%。 一些创新正在为那些寻求乳房植入手术的人提供自然的效果。 微型植入物旨在透过小切口插入乳房组织，提供更自然的效果和最大的舒适度。 一些整形外科医生也在致力于开发轻质硅胶美容植入物，目标是减轻 30% 的重量。 乳房植入物市场是迄今为止医学美容市场中最大的部分，预计在预测期内将加速成长。

本报告对全球乳房植入物市场进行了分析，概述了程序概述、市场基本结构和最新情况、主要市场促进和限制因素、整体市场规模趋势展望以及细分按细分市场和地区划分（所有5 个地区）、主要业务联盟和资本交易（投资、併购等）的最新趋势、当前竞争状况、主要公司概况等。

主要细分市场

依性别

  • 男性
  • 女性

按最终使用者

  • 医院
  • 诊所/医疗水疗中心、皮肤科/美容中心
  • 其他最终用户

依分销通路

  • 直接销售
  • 间接销售

依主要地区划分

  • 北美洲（美国、加拿大、墨西哥）
  • 欧洲（英国、德国、法国、义大利、西班牙等）
  • 亚太地区（中国、韩国、日本、印度）
  • 中东/北非（土耳其、伊朗等）
  • 拉丁美洲（巴西、阿根廷等）

主要市场参与者

  • Allergan Aesthetics
  • BioPlus
  • Collplant
  • GC Aesthetics
  • Mentor
  • Polytech
  • Sientra
  • Symatese

目录

第一章前言

第二章研究方法

第 3 章经济趋势和其他特定于项目的考量

第 4 章执行摘要

第 5 章简介

  • 医美理念
  • 医美的演变
  • 乳房植入物
  • 假体隆乳的优点
  • 乳房植入物的副作用
  • 医美的主要推手因素
  • 最新医疗美容技术
  • 医学美容的主要挑战
  • 未来前景

第六章市场状况

  • 乳房植入物：整体市场情势

第七章公司简介

  • 艾尔建美学
  • 建立实验室
  • 导师

第八章企业竞争力分析

  • 主要先决条件和参数
  • 调查方法
  • 医美：企业竞争力分析

第 9 章伙伴关係与协作

  • 合作伙伴模式
  • 乳房植入物：伙伴关係与协作
  • 按地区分析

第十章融资与投资

  • 融资模式
  • 乳房植入物：资金与投资
  • 结论

第 11 章市场影响分析：驱动因素、限制、机会、挑战

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
  • 结论

第十二章全球乳房植入物市场

  • 主要假设与研究方法
  • 全球乳房植入物市场：过去趋势（2018-2022）与未来预测（2023-2035）
  • 主要细分市场
  • 动态仪表板

第 13 章乳房植入物市场：依最终使用者划分

  • 主要假设与研究方法
  • 乳房植入物市场：依最终使用者划分（2018 年、2023 年、2035 年）
  • 数据测量与验证

第 14 章乳房植入物市场：依性别

  • 主要假设与研究方法
  • 乳房植入物市场：依性别分类（2018、2023、2035）
  • 数据测量与验证

第 15 章乳房植入物市场：依通路划分

  • 主要假设与研究方法
  • 乳房植入物市场：依通路划分（2018 年、2023 年、2035 年）
  • 数据测量与验证

第十六章乳房植入物市场：依主要地区

  • 主要假设与研究方法
  • 乳房植入物市场：依主要地区划分（2018 年、2023 年、2035 年）
  • 数据测量与验证

第十七章乳房植入产品市场

  • 主要假设与研究方法
  • 全球乳房植入产品市场：过去趋势（2018-2022）与未来预测（2023-2035）
  • 乳房植入产品市场：依主要地区划分（2018 年、2023 年、2035 年）
  • 数据测量与验证

第 18 章管理见解

第十九章结论

第 20 章附录 1：表格资料

第 21 章附录 2：公司与组织名单

简介目录
Product Code: RA100470

The breast implants market is valued at USD 19.2 billion in 2023 growing at a CAGR of 9.6% during the forecast period 2023-2035.

Breast implants are one of the most promising treatment options when it comes to body enhancements and surgeries. In fact, it is interesting to know that breast augmentation was among the most popular cosmetic procedures in the world in 2022, with more than 2.17 million operations performed worldwide. The most popular materials used in breast augmentation procedures are saline implants and silicone implants. However, the use of silicone implants by plastic surgeons is more significant, accounting for 17.6 percent of all plastic surgery procedures. This is mainly due to the higher crosslinking rate in silicone implants. In addition, if the implant ruptured or leaked, the gel would not be able to enter the body. Breast cancer is also on the rise, accounting for 12.5 percent of all new yearly cancer cases worldwide.

It is worth noting that breast implants come in various shapes and textures. The purpose of these procedures is to improve breast aesthetics. Patients can choose the best option according to their preferences. The effects of this treatment can last for more than 20 years. However, the chances of implant rupture increase by 1% every year. It is worth mentioning that several innovations are being made to give natural-looking results to people who are looking for breast augmentation. Micro-implants are being developed by researchers in this field. Micro-implants are designed to be inserted into breast tissue through small incisions. They provide more natural-looking results and maximum comfort. Some plastic surgeons are also looking to develop lightweight silicone aesthetic implants. They are trying to reduce weight by 30%. The growth of the breast implant market, which is by far the largest segment of medical aesthetics market, is expected to accelerate over the forecast period.

Key Market Segments

Gender

  • Male
  • Female

End User

  • Hospitals
  • Clincs / Med Spas and Dermatology / Cosmetology Centers
  • Other end users
  • Distribution Channel

Direct Distribution

  • Indirect Distribution

Key Geographical Regions

  • North America (U.S., Canada, Mexico)
  • Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, South Korea, Japan, India)
  • Middle East and North Africa (Turkey, Iran, Rest of the Middle East and North Africa)
  • Latin America (Brazil, Argentina, Rest of the Latin America)

Research Coverage:

The report studies the breast implants market based on gender, end user, distribution channel, and key geographical regions

The report assesses the potential advantages and obstacles within the market for those involved and offers information on the competitive environment for top players in the market.

The report forecasts the revenue of market segments with respect to five major regions

The report provides a general overview of medical aesthetics, including breast implants, benefits and drawbacks of these procedures. Further, the chapter also covers the new technologies applied in this field.

Comprehensive analysis of the current landscape of breast implants developers considering parameters such as establishment year, company size, headquarters, application area and end user

In-depth profiles of companies offering breast implants procedures products and / or devices, focusing on company overviews, financial information (where available), offered dermal filler procedures, recent advancements, and informed future prospects.

Detailed company competitiveness evaluation of breast implants company, considering various parameters.

An analysis of partnerships established in this sector since 2018, covering merger and acquisition, distribution, commercialization, licensing, supply, product development, product and technology integration and manufacturing agreements.

A comprehensive examination of funding and investments made in breast implants companies since 2018, encompassing venture capital financing, secondary offerings, private placements, grants, debt financing, and other equity.

The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.

Key Benefits of Buying this Report:

  • The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
  • Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with a pulse on the breast implants market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Key Market Companies

  • Allergan Aesthetics
  • BioPlus
  • Collplant
  • GC Aesthetics
  • Mentor
  • Polytech
  • Sientra
  • Symatese

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Introduction
  • 1.2. Project Objectives
  • 1.3. Scope of the Report
  • 1.4. Inclusions and Exclusions
  • 1.5. Key Questions Answered
  • 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

  • 2.1. Chapter Overview
  • 2.2. Research Assumptions
  • 2.3. Project Methodology
  • 2.4. Forecast Methodology
  • 2.5. Robust Quality Control
  • 2.6. Key Market Segmentations
  • 2.7. Key Considerations
    • 2.7.1. Demographics
    • 2.7.2. Economic Factors
    • 2.7.3. Government Regulations
    • 2.7.4. Supply Chain
    • 2.7.5. COVID Impact / Related Factors
    • 2.7.6. Market Access
    • 2.7.7. Healthcare Policies
    • 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

  • 3.1. Chapter Overview
  • 3.2. Market Dynamics
    • 3.2.1. Time Period
      • 3.2.1.1. Historical Trends
      • 3.2.1.2. Current and Forecasted Estimates
    • 3.2.2. Currency Coverage
      • 3.2.2.1. Overview of Major Currencies Affecting the Market
      • 3.2.2.2. Impact of Currency Fluctuations on the Industry
    • 3.2.3. Foreign Exchange Impact
      • 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
      • 3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
    • 3.2.4. Recession
      • 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
      • 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
    • 3.2.5. Inflation
      • 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

  • 5.1. Chapter Overview
  • 5.2. Concept of Medical Aesthetics
  • 5.3. Evolution of Medical Aesthetics
  • 5.4. Breast Implants
  • 5.5. Advantages of Breast Implants
  • 5.6. Side Effects of Breast Implants
  • 5.7. Key Growth Drivers of Medical Aesthetics
  • 5.8. Emerging Technologies in Medical Aesthetics
    • 5.8.1. Virtual Reality in Medical Aesthetics
    • 5.8.2. Augmented Reality in Medical Aesthetics
    • 5.8.3. Artificial Intelligence in Medical Aesthetics
    • 5.8.4. Telemedicine in Medical Aesthetics
  • 5.9. Key Challenges of Medical Aesthetics
  • 5.10. Future Perspectives

6. MARKET LANDSCAPE

  • 6.1. Chapter Overview
  • 6.2. Breast Implants: Overall Market Landscape
    • 6.2.1. Analysis by Year of Establishment
    • 6.2.2. Analysis by Company Size
    • 6.2.3. Analysis by Location of Headquarters (Region)
    • 6.2.4. Analysis by Location of Headquarters (Country)
    • 6.2.5. Analysis by Year of Establishment and Location of Headquarters (Region)
    • 6.2.6. Analysis by Company Size and Location of Headquarters (Region)
    • 6.2.7. Analysis by Application Area
    • 6.2.8. Analysis by End-user

7. COMPANY PROFILES

  • 7.1. Chapter Overview
  • 7.2. Allergan Aesthetics
    • 7.2.1. Company Overview
    • 7.2.2. Financial Information
    • 7.2.3. Medical Aesthetics Portfolio
    • 7.2.4. Recent Developments and Future Outlook
  • 7.3. Establishment Labs
    • 7.3.1. Company Overview
    • 7.3.2. Financial Information
    • 7.3.3. Medical Aesthetics Portfolio
    • 7.3.4. Recent Developments and Future Outlook
  • 7.4. Mentor
    • 7.4.1. Company Overview
    • 7.4.2. Medical Aesthetics Portfolio
    • 7.4.3. Recent Developments and Future Outlook

8. COMPANY COMPETITIVENESS ANALYSIS

  • 8.1. Chapter Overview
  • 8.2. Key Assumptions and Parameters
  • 8.3. Methodology
  • 8.4. Medical Aesthetics: Company Competitiveness Analysis
    • 8.4.1. Companies based in North America
    • 8.4.2. Companies based in Europe
    • 8.4.3 Companies based in Asia-Pacific and Rest of the World

9. PARTNERSHIPS AND COLLABORATIONS

  • 9.1. Chapter Overview
  • 9.2. Partnership Models
  • 9.3. Breast Implants: Partnerships and Collaborations
    • 9.3.1. Analysis by Year of Partnership
    • 9.3.2. Analysis by Type of Partnership
    • 9.3.3. Analysis by Year and Type of Partnership
    • 9.3.4. Analysis by Focus Area
    • 9.3.5. Most Active Players: Analysis by Number of Partnerships
  • 9.4. Analysis by Geography
    • 9.4.1. Local and International Agreements
    • 9.4.2. Intracontinental and Intercontinental Agreements

10. FUNDING AND INVESTMENTS

  • 10.1. Chapter Overview
  • 10.2. Funding Models
  • 10.3. Breast Implants: Funding and Investments
    • 10.3.1. Analysis by Year of Funding
    • 10.3.2. Analysis by Amount Invested
    • 10.3.3. Analysis by Type of Funding
    • 10.3.4. Analysis by Year and Type of Funding
    • 10.3.5. Analysis by Type of Funding and Amount Invested
    • 10.3.6. Analysis by Geography
    • 10.3.7. Most Active Players
      • 10.3.7.1. Analysis by Number of Funding Instances
      • 10.3.7.2. Analysis by Amount Raised
    • 10.3.9. Analysis by Company Size and Amount Invested
    • 10.3.10. Leading Investors: Analysis by Number of Funding Instances
  • 10.4. Concluding Remarks

11. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

  • 11.1. Chapter Overview
  • 11.2. Market Drivers
  • 11.3. Market Restraints
  • 11.4. Market Opportunities
  • 11.5. Market Challenges
  • 11.6. Conclusion

12. GLOBAL BREAST IMPLANTS MARKET

  • 12.1. Chapter Overview
  • 12.2. Key Assumptions and Methodology
  • 12.3. Global Breast Implants Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 12.3.1. Scenario Analysis
      • 12.3.1.1. Conservative Scenario Analysis
      • 12.3.1.2. Optimistic Scenario Analysis
  • 12.4. Key Market Segmentations
  • 12.5. Dynamic Dashboards

13. BREAST IMPLANTS MARKET, BY END-USER

  • 13.1. Chapter Overview
  • 13.2. Key Assumptions and Methodology
  • 13.3. Breast Implants Market: Distribution by End-user, 2018, 2023 and 2035
    • 13.3.1. Hospitals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 13.3.2. Clinics / Med Spas and Dermatology / Cosmetology Centers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 13.3.3. Other End-users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 13.4. Data Triangulation and Validation

14. BREAST IMPLANTS MARKET, BY GENDER

  • 14.1. Chapter Overview
  • 14.2. Key Assumptions and Methodology
  • 14.3. Breast Implants Market: Distribution by Gender, 2018, 2023 and 2035
    • 14.3.1. Females: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.2. Males: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 14.4. Data Triangulation and Validation

15. BREAST IMPLANTS MARKET, BY DISTRIBUTION CHANNEL

  • 15.1. Chapter Overview
  • 15.2. Key Assumptions and Methodology
  • 15.3. Breast Implants Market, by Distribution Channel, 2015, 2023 and 2035
    • 15.3.1. Direct Distribution: Historical Trends (2015-2022) and Forecasted Estimates (2023-2035)
    • 15.3.2. Indirect Distribution: Historical Trends (2015-2022) and Forecasted Estimates (2023-2035)
  • 15.4. Data Triangulation and Validation

16. BREAST IMPLANTS MARKET, BY KEY GEOGRAPHICAL REGION

  • 16.1. Chapter Overview
  • 16.2. Key Assumptions and Methodology
  • 16.3. Breast Implants Market: Distribution by Key Geographical Regions, 2016, 2023 and 2035
    • 16.3.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.1.1. US: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.1.2. Canada: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.1.3. Mexico: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 16.3.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.1. UK: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.2. Germany: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.3. France: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.4. Italy: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.5. Spain: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.5. Rest of the Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 16.3.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.3.1. China: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.3.2. South Korea Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.3.3. Japan: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.3.4. India: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 16.3.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.4.1. Turkey: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.4.2. Iran: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.4.3. Rest of the Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 16.3.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.5.1. Brazil: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.5.2. Argentina: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.5.3. Rest of the Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 16.4. Data Triangulation and Validation

17. BREAST IMPLANTS PRODUCT MARKET

  • 17.1. Chapter Overview
  • 17.2. Key Assumptions and Methodology
  • 17.3. Global Breast Implants Product Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 17.4. Breast Implants Products Market, by Key Geographical Regions, 2018, 2023 and 2035
    • 17.4.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.4.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.4.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.4.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.4.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 17.5. Data Triangulation and Validation

18. EXECUTIVE INSIGHTS

19. CONCLUSION

20. APPENDIX 1: TABULATED DATA

21. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS